Impact of Sinus Surgery on Individuals With Cystic Fibrosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-99
SponsorUniversity of California, Los Angeles
About this trial
This study will be a prospective, observational study of patients who undergo endoscopic sinus surgery for cystic fibrosis-related chronic rhinosinusitis (CRS). Individuals who do not undergo surgery but are treated medically for CRS will also be enrolled to serve as a control group. Outcomes analyzed will include pulmonary, quality of life, and others.
Eligibility criteria
Qualifiers
Subjects between the ages of 18 years old (inclusive) and 99 years old (inclusive, subjects over the age of 89 will be recorded to be 89 years old).
Diagnosed with cystic fibrosis as established by genetic testing combined with clinical assessment and/or sweat chloride
Diagnosed with chronic rhinosinusitis by multidisciplinary sinusitis guidelines
chronic rhinosinusitis symptoms persisting beyond initial medical treatment
Disqualifiers
Underwent endoscopic sinus surgery in past 12 months
Will obtain follow up care at non-participating institutions
Unable to complete follow-up surveys
Trial design
Treatments tested in this trial
- Not listed
Trial groups
170 Participants
are grouped into 2 trial groupsSponsors and collaborators
University of California, Los Angeles
Lead sponsor
Cystic Fibrosis Foundation
Collaborator
Source ClinicalTrials.gov